Real-time enrollment status for this kcnt1-related epilepsy clinical trial
Current Status
Recruiting
Checked: October 20, 2026 at 3:55 AM UTC
| NCT Number | NCT07600736 |
| Recruiting Status | Recruiting |
| Condition | KCNT1-Related Epilepsy |
| Phase | PHASE2 |
| Target Enrollment | 61 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Actio Biosciences, Inc. |
| Last Updated on CT.gov | October 15, 2026 (5 days ago) |
As of October 20, 2026: Clinical trial NCT07600736 is currently recruiting participants. This phase2 study for kcnt1-related epilepsy is actively seeking new participants at 2 locations across the United States. The study is sponsored by Actio Biosciences, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07600736 is actively recruiting participants as of October 20, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07600736 was last updated 5 days ago (October 15, 2026). HelloStudys verifies this status automatically.